94.79
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Alcon Inc Aktie (ALC) Neueste Nachrichten
Ex-Dividend Reminder: Consolidated Edison, WEC Energy Group and Alcon - Nasdaq
Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Fund Update: THORNBURG INVESTMENT MANAGEMENT INC added 249,767 shares of ALCON ($ALC) to their portfolio - Nasdaq
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - Stock Titan
Alcon Announces Results of 2025 Annual General Meeting | ALC Stock News - GuruFocus
Alcon Announces Results of 2025 Annual General Meeting - Business Wire
Institutional investors are Alcon Inc.'s (VTX:ALC) biggest bettors and were rewarded after last week's CHF1.2b market cap gain - simplywall.st
Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL.com
Do Options Traders Know Something About Alcon Stock We Don't? - Nasdaq
RBC Bets On Alcon's Growth With Continued Outperform Rating - Finimize
RBC Keeps Alcon at Outperform Ahead of Q1 Results - marketscreener.com
Alcon (ALC) Gets a Buy from RBC Capital - The Globe and Mail
Alcon Rolls Out Unity Vitreoretinal and Cataract Surgery Systems - Medical Product Outsourcing
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior E - GuruFocus
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS - marketscreener.com
Corneal Topographers Market Deep Research 2025-2032 | Alcon plc., Abbott Laboratories, Topcon Corporation - openPR.com
WCO & Alcon Dry Eye Wheel launches in French - childrennow.co.uk
Village Roadshow’s $417.5 Million Stalking Horse Deal Approved - Bloomberg.com
Alcon Entertainment Appoints Former MGM Exec Steven Johnson As EVP, Head Of Physical Production - IMDb
Alcon lines up product launches in India, bets on rising demand for advanced eye care - MSN
Lobbying Update: $150,000 of ALCON VISION LLC lobbying was just disclosed - Nasdaq
Aniridia Treatment Market Is Going to Boom | Major Giants Alcon, Santen Pharmaceutical, Johnson & Johnson Vision - openPR.com
There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital - Yahoo Finance
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC) - Seeking Alpha
GE HealthCare Hires Alcon Exec Jeannette Bankes as Patient Care Solutions CEO - Medical Product Outsourcing
Ophthalmic Devices Market Set to Attain Valuation of US$ 83.33 Billion By 2033 | Astute Analytica - GlobeNewswire Inc.
Here’s Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC) - Insider Monkey
Tesla, Warner Bros fend off some claims in 'Blade Runner 2049' ad dispute - Reuters
Alcon (VTX:ALC) Seems To Use Debt Quite Sensibly - simplywall.st
Alcon Scoops Up Aurion Biotech With Intent of Advancing Ophthalmology Cell Therapy AURN001 - CGTLive®
US Tariffs Challenge Carl Zeiss Meditec And Smith & Nephew - Finimize
Bernstein raises Alcon stock price target to CHF99 from CHF97.50 - Investing.com Canada
Alcon, Aurion Reach Accord in Dispute Over Public Offering - Bloomberg Law News
Bernstein raises Alcon stock price target to CHF99 from CHF97.50 By Investing.com - Investing.com South Africa
Dr. Jeffrey Martin of SightMD Becomes One of the First on Long Island to Implant the new Clareon® PanOptix® Pro Lens by Alcon - PRWeb
Alcon Publishes Agenda for 2025 Annual General Meeting - Business Wire
ALC Stock May Rise With the Introduction of PanOptix Pro in US - MSN
Alcon Introduces Clareon PanOptix Pro Intraocular Lens - Medical Product Outsourcing
Alcon Expands Leadership in IOL Innovation with Clareon PanOptix - GuruFocus
Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter – Company AnnouncementFT.com - Financial Times
Game-Changing Cataract Lens: Alcon's New PanOptix Pro Achieves Record 94% Light Efficiency - Stock Titan
The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals - Yahoo Finance
Dry Eye Disease Market Growth in Future Scope 2025-2032 | - openPR.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):